-
Drug Repurposing for CRISPR DNA Repair Control
2026-08-19
The reference study presents a large-scale repurposing screen showing that clinically approved drugs can shift CRISPR-induced double-strand break repair toward NHEJ, MMEJ, or HDR. Its identification of ESR2 and AOX1 as pathway-relevant regulators, together with drug-induced synthetic lethality, creates a mechanistic framework for improving genome editing and exploring precision cancer vulnerabilities.
-
Gramine Workflows for Ferroptosis Research
2026-08-18
Gramine provides a mechanism-guided way to study ferroptosis in triple-negative breast cancer models, linking CUL3 target engagement with MTDH regulation and downstream oxidative injury. This workflow combines dose-response screening, orthogonal binding assays, rescue experiments, and practical handling guidance for more reproducible cancer biology research.
-
Degarelix Acetate: Assay Workflows and Optimization
2026-08-18
Degarelix acetate supports precise GnRH pathway interrogation, from receptor-linked hormone secretion assays to prostate cancer research models. Its additional value in formulation work is revealed by 1H NMR aggregation analysis, enabling researchers to separate pharmacology questions from peptide stability effects.
-
(S)-(+)-Ibuprofen COX Inhibitor Workflow
2026-08-17
Build more reproducible inflammation assays with the pharmacologically active (S)-(+)-Ibuprofen enantiomer, from soluble stock preparation through COX-focused endpoint selection. The same compound also supports carefully controlled ecotoxicology and biodegradation studies, provided its environmental activity is interpreted separately from mammalian pharmacology.
-
NMDA in Excitotoxicity and Ferroptosis Models
2026-08-17
NMDA (N-Methyl-D-aspartic acid) provides a controlled way to connect receptor-driven excitotoxicity with calcium dysregulation, oxidative stress, and ferroptosis. This article presents a phenotype-first workflow informed by a recent glaucoma study and explains how to select orthogonal assays for stronger mechanistic interpretation.
-
Murine RNase Inhibitor: RNA Protection
2026-08-16
Murine RNase Inhibitor is a 50 kDa recombinant mouse protein that binds pancreatic-type RNases, including RNase A, in a 1:1 ratio. Its reported resistance to oxidative inactivation supports RNA degradation prevention in real-time RT-PCR, cDNA synthesis, and in vitro transcription workflows.
-
Nadolol (SQ-11725) for Reliable Cell Assays
2026-08-15
This scenario-based guide explains how Nadolol (SQ-11725), SKU BA5097, can be incorporated into cell viability, proliferation, and transporter-aware workflows without confusing pharmacology with assay noise. It covers experimental design, stock preparation, data interpretation, and practical vendor-selection criteria supported by product information and recent pharmacokinetic literature.
-
GSH-Responsive MOF Nanoparticles for Melanoma Therapy
2026-08-14
This 2023 study developed ICG-loaded, AUNP12-functionalized metal–organic framework nanoparticles that combine photothermal therapy with tumor-localized PD-1/PD-L1 blockade. The GSH-responsive design enabled near-infrared heating, immune-stimulatory activity, and controlled release of the checkpoint-blocking polypeptide within a single nanoplatform.
-
S-Adenosylhomocysteine in Neural Assays
2026-08-14
S-Adenosylhomocysteine is more than a methylation-cycle intermediate: it is a ratio-aware tool for studying methyltransferase inhibition and metabolic context. This article connects SAH assay design with radiation-induced neuronal differentiation while clearly separating established evidence from exploratory applications.
-
Hydroxychloroquine Sulfate Workflow Guide
2026-08-13
Hydroxychloroquine Sulfate (SKU B4874) provides an aqueous-compatible research tool for studying autophagy pathway modulation and TLR7/9-dependent immune signaling in autoimmune disease research. It is suited to short-term cell and animal workflows, but should not be selected when DMSO or ethanol solubility or long-term solution storage is required.
-
Cy5 Detection for ASB3–MAVS Translational Research
2026-08-13
A mechanism-driven guide to using Cy5 fluorescence to validate ASB3-mediated MAVS degradation, strengthen antiviral signaling assays, and translate pathway observations into more reliable research decisions.
-
Z-WEHD-FMK in Pyroptosis Assays
2026-08-12
Z-WEHD-FMK enables time-controlled, irreversible inhibition of inflammatory caspases in pyroptosis, pathogen–host, and cancer-cell workflows. This guide connects product-specific handling with the HOXC8–caspase-1 findings and provides practical assay design, controls, and troubleshooting strategies.
-
Direct Mouse Genotyping Kit Plus for Macrophage Studies
2026-08-12
Connect rapid, purification-free mouse genotyping with demanding lineage-tracing and liver metastasis workflows. The Direct Mouse Genotyping Kit Plus supports transgene detection, gene knockout validation, and colony screening while reducing transfers between tissue lysis and endpoint PCR.
-
RNA Clean and Concentrator Kit for mRNA-LNP
2026-08-11
Discover how the RNA Clean and Concentrator Kit can support disciplined in vitro transcription RNA cleanup before mRNA-LNP research. This article connects RNA purification decisions with the localized p21 mRNA delivery strategy reported for bladder cancer.
-
IPCRL1 Knockdown Protects Against Myocardial I/R Injury
2026-08-11
The reference study identifies IPCRL1 as a mechanistic regulator of myocardial ischemia/reperfusion injury, linking its knockdown to the miR-185-3p/JIP3 axis and JNK-associated apoptosis. Its combined mouse, cardiomyocyte, molecular, and functional assays provide a framework for evaluating lncRNA-mediated cardioprotection and related gene expression changes.